机译:S-亚硝基-N-乙酰基-L-半胱氨酸乙酯(SNACET)和N-乙酰基-L-半胱氨酸乙酯(NACET)–基于半胱氨酸的候选药物,具有独特的药理学特征,可作为NO,H2S和GSH的供应商进行口服作为抗氧化剂:结果和概述
Institute of Toxicology,Core Unit Proteomics,Hannover Medical School,30623 Hannover,Germany;
Institute of Toxicology,Core Unit Proteomics,Hannover Medical School,30623 Hannover,Germany;
Second Department of Cardiology,Jagiellonian University Medical College,Cracow,Poland;
Department of Medicine,Surgery and Neuroscience,University of Siena,53100 Siena,Italy;
Department of Life Sciences,Laboratory of Pharmacology and Toxicology,University of Siena,53100 Siena,Italy;
Department of Analytical Chemistry,Faculty of Chemistry and Technology,University of Split,21000 Split,Croatia;
Department of Urology and Urological Oncology,Hannover Medical School,30623 Hannover,Germany;
Department of Urology and Urological Oncology,Hannover Medical School,30623 Hannover,Germany;